Abzyme Therapeutics
Steve has over 25 years of global sales, marketing and business development experience. For a significant part of his professional career he has been working in the pharmaceutical R&D service industry. Steve has a broad knowledge and expertise in the global research and development marketplace. He has a successful track record of creating and executing go-to-market business development strategies to effectively drive double digit revenue growth. Prior to joining Abzyme, he was the Vice President of Global Sales and Business Development for GENEWIZ. Steve holds a Bachelor’s degree in Economics from Syracuse University and an MBA from Regis University, Denver Colorado.
This person is not in any offices
Abzyme Therapeutics
Abzyme Therapeutics is a biopharmaceutical company focused on developing modular single domain VHH antibody fragments for immunotherapy using proprietary antibody generation platforms.